TrialPharmacology research & perspectives2017

Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers.

Kathleen Weisel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.